Healthy Skepticism Library item: 9285

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Dowie J.
Transparency in NICE
BMJ 2007 Apr 7; 334:(7596):709
http://www.bmj.com/cgi/content/full/334/7596/709-a

Abstract:

Let’s open whole process of cost effective modelling

The National Institute for Health and Clinical Excellence (NICE) needs to go much further than allowing access to its modelling data.1 The whole cost effectiveness modelling process needs to be opened up to involvement by all stakeholders, and inspection by the public, as it happens. The independent group should be contracted to develop the one and only model that NICE will consider in its appraisal, and it should do so in full and continuous collaboration with all registered stakeholders and interested parties who sign up to the NICE guidelines. The model will be run with any alternative parameters suggested by various parties and the alternative results (along with their evidential basis) submitted to the appraisal committee in a single report. No subsequent questioning of, or submissions regarding, the model structure, the results, or the underlying principles would be accepted in the context of any particular case…